Developing treatments and vaccines for COVID-19 and other infectious diseases.
Official title: Research Resources and Workforce Development for the Rocky Mountain Regional Biocontainment Laboratory at Colorado State University
Funded at Colorado State University · NIH-10910196 · Data updated 2026-11-12
This study at Colorado State University is looking into new treatments and vaccines for COVID-19 and other infectious diseases, aiming to help people stay healthy and better prepared for future outbreaks.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Colorado State University NIH-funded |
| Lab location | 1 site (Fort Collins, United States) |
| Project start | August 18, 2023 |
| Project end | July 31, 2028 |
| Funding year | 2024 |
| Award (this year) | $2,877,411 |
| NIH project number | 5UC7AI180308-02 |
| Project ID | NIH-10910196 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for participation or benefit include adults aged 21 and older who are at risk for or affected by COVID-19 and other infectious diseases.
✕Less likely to help
Patients who are not adults or those with conditions unrelated to infectious diseases may not receive benefit from this research.
What this research studies
The Rocky Mountain Regional Biocontainment Laboratory at Colorado State University focuses on researching biodefense and emerging infectious diseases, particularly in response to COVID-19. The lab conducts studies on host-derived therapeutics and vaccines while also investigating zoonotic reservoirs that may contribute to disease spread. Additionally, the facility provides training and outreach programs to enhance public health preparedness. Patients may benefit from advancements in treatment options and preventive measures against infectious diseases.
Why it matters
Potential benefit: If successful, this research could lead to effective treatments and vaccines for COVID-19 and other infectious diseases, improving public health outcomes.
How similar studies have gone: Previous research in biodefense and infectious disease response has shown success in developing effective treatments and vaccines, indicating a promising approach.
Where this research is happening
-
Colorado State University
Fort Collins, United States Active
Researchers
- Principal investigator: Dobos, Karen Marie — Colorado State University
- Study coordinator: Dobos, Karen Marie
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.